dcterms.isReferencedBy |
Stuart, P., Malick, F., Nair, R.P., Henseler, T., Lim, H.W., Jenisch, S., Analysis of phenotypic variation in psoriasis as a function of age at onset and family history (2002) Arch Dermatol Res, 294, pp. 207-213; Krueger, G.G., Langley, R.G., Leonardi, C., Yeilding, N., Guzzo, C., Wang, Y., A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis (2007) N Engl J Med, 356, pp. 580-592; Dickinson, D.P., Cysteine peptidases of mammals: Their biological roles and potential effects in the oral cavity and other tissues in health and disease (2002) Crit Rev Oral Biol Med, 13, pp. 238-275; Turk, B., Stoka, V., Rozman-Pungercar, J., Cirman, T., Droga-Mazovec, G., Oreic, K., Apoptotic pathways: Involvement of lysosomal proteases (2002) Biol Chem, 383, pp. 1035-1044; Hopkins, A.L., Groom, C.R., The druggable genome (2002) Nat Rev Drug Discov, 1, pp. 727-730; Tang, J., Wong, R.N., Evolution in the structure and function of aspartic proteases (1987) J Cell Biochem, 33, pp. 53-63; Hsueh, W.A., Baxter, J.D., (1991) Human Prorenin. Hypertension, 17, pp. 469-477; Sato, K., Waguri, S., Nitatori, T., Kon, S., Kominami, E., Watanabe, T., Immunocytochemical localization of lysosomal cysteine and aspartatic proteinases, and ubiquitin in rat epidermis (1997) Arch Histol Cytol, 30, pp. 275-287; Kawada, A., Hara, K., Kominami, E., Hiruma, M., Noguchi, H., Ishibashi, A., Processing of cathepsins L, B and D in psoriatic epidermis (1997) Arch Dermatol Res, 289, pp. 87-93; Horikoshi, T., Igarishi, S., Uchiwa, H., Brysk, H., Brysk, M.M., Role of endogenous cathepsin D-like and chymotrypsin-like proteolysis in human epidermal desquamation (1999) Br J Dermatol, 141, pp. 453-459; Serre, G., Mils, V., Haftek, M., Vincent, C., Croute, F., R�ano, A., Identification of late differentiation antigens of human cornified epithelia, expressed in reorganized desmosomes and bound to cross-linked envelope (1991) J Invest Dermatol, 97, pp. 1061-1072; Igarashi, S., Takizawa, T., Takizawa, T., Yasuda, Y., Uchiwa, H., Hayashi, S., Cathepsin D, but not cathepsin E, degrades desmosomes during epidermal desquamation (2004) Br J Dermatol, 151, pp. 355-361; Lazarus, G.S., Poole, R., Immunocytochemical localization of cathepsin D in rabbit skin (1975) Arch Dermatol, 111, pp. 1150-1153; Horikoshi, T., Arany, I., Rajaraman, S., Chen, S.-H., Brysk, H., Lei, G., Isoforms of cathepsin D and human epidermal differentiation (1998) Biochimie (Paris), 80, pp. 605-612; Egberts, F., Heinrich, M., Jensen, J.M., Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation (2004) J Cell Sci, 117, pp. 2295-2307; Vashishta, A., Saraswat Ohri, S., Vetvickova, J., Fusek, M., Ulrichova, J., Vetvicka, V., Procathepsin D secreted by HaCaT keratinocyte cells - a novel regulator of keratinocyte growth (2007) Eur J Cell Biol, 86, pp. 303-313; Rice, R.H., Green, H., Presence in human epidermal cells of a soluble protein precursor of the crosslinked envelope: Activation of the cross-linking by calcium ions (1979) Cell, 18, pp. 681-694; Dover, R., Watt, F.M., Measurement of the rate of epidermal terminal differentiation: Expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques (1987) J Invest Dermatol, 89, pp. 349-352; Watt, F.M., Boukamp, P., Hornung, J., Fusenig, N.E., Effect of growth environment on spatial expression of involucrin by human epidermal keratinocytes (1987) Arch Dermatol Res, 279, pp. 335-340; Negi, M., Matsui, T., Ogawa, H., Mechanism of human epidermal transglutaminase (1981) J Invest Dermatol, 77, pp. 389-392; Chen, S.H., Arany, I., Apisarnthanarax, N., Rajaraman, S., Tyring, S.K., Horikoshi, T., Response of keratinocytes from normal and psoriatic epidermis to interferon- gamma differs in the expression of zincalpha(2)-glycoprotein and cathepsin D (2000) FASEB J, 14, pp. 565-571; Minarowska, A., Gacko, M., Karwowska, A., Minarowski, L., Human cathepsin D (2008) Folia Histochem Cytobiol, 46, pp. 23-38; Berchem, G.J., Glondu, M., Gleizes, M., Brouillet, J.P., Garcia, M., Liaudet-Coopman, E., Cathepsin-D affects multiple steps of tumor progression: Proliferation, angiogenesis and apoptosis (2002) Oncogene, 21, pp. 5951-5955; Abdou, A.G., Hanout, H.M., Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study (2008) J Cutan Pathol, 35, pp. 445-451; Gonzlez-Vela, M.C., Garijo, M.F., Fernndez, F., Buelta, L., Val-Bernal, J.F., Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma (1999) Histopathology, 34, pp. 35-42; Lsch, A., Schindl, M., Kohlberger, P., Lahodny, J., Breitenecker, G., Horvat, R., Cathepsin D in ovarian cancer: Prognostic value and correlation with p53 expression and microvessel density (2004) Gynecol Oncol, 92, pp. 545-552; Briozzo, P., Badet, J., Capony, F., Pieri, I., Montcourrier, P., Barritault, D., MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: A permissive role of cathepsin D (1991) Exp Cell Res, 194, pp. 252-259; Piwnica, D., Fernandez, I., Binart, N., Touraine, P., Kelly, P.A., Goffin, V., A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D (2006) Mol Endocrinol, 20, pp. 3263-3278; Vallat, V.P., Gilleaudeau, P., Battat, L., Wolfe, J., Nabeya, R., Heftler, N., PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: A possible cellular basis for remittive therapy (1994) J Exp Med, 180, pp. 283-296 |
|